["{\n\"step_by_step_thinking\": \"The patient is a 23-year-old woman, gravida 2, para 1, at 28 weeks' gestation. She has an Rh-negative blood type and her baby's father has an Rh-positive blood type. This is a risk factor for hemolytic disease of the fetus and newborn (HDFN). Therefore, administration of Rh immunoglobulin (Rh IgG) is appropriate to prevent HDFN.\",\n\"answer_choice\": \"B: Anti-D IgG\"\n}"]